HSBC Holdings
MRNA icon

HSBC Holdings’s Moderna MRNA Stock Holding History

HSBC Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.6M Sell
490,088
-148,282
-23% -$6.92M 0.01% 686
2025
Q4 		$18.9M Sell
638,370
-107,077
-14% -$2.91M 0.01% 767
2025
Q3 		$18.9M Buy
745,447
+164,297
+28% +$4.58M 0.01% 738
2025
Q2 		$16.1M Sell
581,150
-51,521
-8% -$1.36M 0.01% 765
2025
Q1 		$17.9M Sell
632,671
-19,893
-3% -$706K 0.01% 742
2024
Q4 		$27M Buy
652,564
+37,473
+6% +$1.79M 0.02% 656
2024
Q3 		$41M Buy
615,091
+151,648
+33% +$13.9M 0.02% 534
2024
Q2 		$55M Sell
463,443
-66,694
-13% -$8.44M 0.03% 428
2024
Q1 		$56.5M Sell
530,137
-108,528
-17% -$10.9M 0.04% 432
2023
Q4 		$63.5M Buy
638,665
+892
+0.1% +$75K 0.06% 344
2023
Q3 		$65.8M Buy
637,773
+65,314
+11% +$7.29M 0.07% 301
2023
Q2 		$69.7M Buy
572,459
+188,075
+49% +$25.1M 0.07% 282
2023
Q1 		$59M Sell
384,384
-83,142
-18% -$13.7M 0.07% 286
2022
Q4 		$83.7M Buy
467,526
+78,153
+20% +$12.8M 0.1% 212
2022
Q3 		$46.2M Buy
389,373
+44,260
+13% +$6.72M 0.08% 264
2022
Q2 		$49.5M Buy
345,113
+22,345
+7% +$3.19M 0.07% 284
2022
Q1 		$56M Sell
322,768
-31,006
-9% -$5.22M 0.07% 280
2021
Q4 		$89.6M Sell
353,774
-14,246
-4% -$4.17M 0.08% 221
2021
Q3 		$141M Buy
368,020
+282,230
+329% +$104M 0.14% 121
2021
Q2 		$20.1M Sell
85,790
-30,220
-26% -$5.4M 0.02% 623
2021
Q1 		$14.8M Buy
116,010
+34,762
+43% +$5.04M 0.02% 687
2020
Q4 		$8.61M Sell
81,248
-16,465
-17% -$1.67M 0.01% 833
2020
Q3 		$6.97M Buy
97,713
+42,349
+76% +$2.95M 0.01% 831
2020
Q2 		$3.56M Buy
55,364
+46,565
+529% +$2.55M 0.01% 969
2020
Q1 		$261K Buy
+8,799
New +$202K ﹤0.01% 2132

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings's MRNA Position: Q1 2026 in Review

HSBC Holdings reduced its Moderna (MRNA) stake by 23% in Q1 2026, selling an estimated $6.92M and leaving 490,088 shares worth $24.6M. The position accounts for 0.01% of the portfolio, ranked #686.

HSBC Holdings first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $141M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • HSBC Holdings held 490,088 shares of Moderna worth $24.6M as of Q1 2026.
  • HSBC Holdings sold 148,282 Moderna shares in Q1 2026, an estimated $6.92M.
  • Moderna made up 0.01% of HSBC Holdings's portfolio in Q1 2026, its #686 holding.
  • HSBC Holdings first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
  • HSBC Holdings's Moderna position peaked at $141M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.